Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2005
12/08/2005WO2005116057A1 Monoclonal antibody against abca1
12/08/2005WO2005116056A1 Hla-a24- or hla-a2-binding peptide of parathyroid hormone-related protein
12/08/2005WO2005116055A1 Peptides, antibodies and compositions containing same useful for treating hiv virus infection
12/08/2005WO2005116052A2 ANTAGONISM OF TGF-β SUPERFAMILY RECEPTOR SIGNALING
12/08/2005WO2005116051A2 Tumor-associated peptides that bind to mhc-molecules
12/08/2005WO2005115478A2 Methods and compositions for autism spectrum disorders
12/08/2005WO2005115468A1 Novel drug discovery target and medicine acting on the same
12/08/2005WO2005115454A2 Methods and compositions for cancer treatment relating to brca1 brct domain recognition of phosphorylated bach1
12/08/2005WO2005115448A2 Multi plasmid system for the production of influenza virus
12/08/2005WO2005115436A1 Soluble lfa-3 polypeptide for treating viral disorders
12/08/2005WO2005115434A1 Therapeutic compositions and methods for treating hpv induced skin cancer
12/08/2005WO2005115430A1 Treatment of inflammatory airway disease
12/08/2005WO2005115306A2 Keratin-binding polypeptides
12/08/2005WO2005115303A1 Purification of insulin-like material by reverse phase chromatography
12/08/2005WO2005115174A2 Alpha-msh-antagonist didpeptide conjugates
12/08/2005WO2005115113A2 Polypeptides for inducing a protective immune response against staphylococcus aureus
12/08/2005WO2005100586A3 Method for construction and use of kluyveromyces lactis promoter variants in k.lactis that substantially lack e. coli transcriptional capability
12/08/2005WO2005097828A3 Peptides of cav2.2 that inhibit pain
12/08/2005WO2005093069A3 Production of mersacidin and its variants in sigh and/or mrsa negative bacillus host cells
12/08/2005WO2005092921A3 Placental growth factor splice variants and their uses
12/08/2005WO2005091956A3 In vitro test system for predicting patient tolerability of therapeutic agents
12/08/2005WO2005089737A3 Materials and methods for inhibiting wip1
12/08/2005WO2005087261A3 Identification of self and non-self antigens implicated in autoimmune diseases
12/08/2005WO2005080424A3 Peptide yy analogues
12/08/2005WO2005078075A3 Hybrid proteins of active-site serine beta-lactamase
12/08/2005WO2005077018A3 Methods of treating skin disorders
12/08/2005WO2005076013A3 Process for screening glycoform-specific antibodies
12/08/2005WO2005075679A3 Antigenic hiv-1 peptides
12/08/2005WO2005075448A3 A method for manufacturing optically pure coumaryl amino acids salts and the coumaryl amino acid salts thus obtained
12/08/2005WO2005074968A3 Medical use of basic peptides
12/08/2005WO2005068645B1 Anticariogenic proteins & peptides & saccharides
12/08/2005WO2005068640A3 Modified ksa and uses thereof
12/08/2005WO2005067410A3 Synthetic nucleic acids from aquatic species
12/08/2005WO2005051662A3 Methods for detecting l-ficolin dependent activation of the lectin pathway of complement and kits therefor
12/08/2005WO2005047526A3 Method for identifying inhibitors using a homology model of polo-like kinase 1
12/08/2005WO2005041882A3 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
12/08/2005WO2005000875A3 Compositions and methods comprising a ligand of chemerin receptor
12/08/2005WO2004066948A3 Mapcaxs as modifiers of the apc and axin pathways and methods of use
12/08/2005WO2004050704A8 Therapeutic and diagnostic agents
12/08/2005WO2004039958A3 Lutzomyia longipalpis polypeptides and methods of use
12/08/2005WO2004005468A3 Axs gene and protein and methods related thereto
12/08/2005WO2003104263A3 Cytokines and cytokine receptors with reduced immunogenicity
12/08/2005WO2003060148A3 Androgen regulated nucleic acid molecules and encoded proteins
12/08/2005WO2002066494A3 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
12/08/2005US20050273884 PUFA polyketide synthase systems and uses thereof
12/08/2005US20050273883 Pufa polyketide synthase systems and uses thereof
12/08/2005US20050273882 Expression of Cry3B insecticidal protein in plants
12/08/2005US20050273881 Defensin polynucleotides and methods of use
12/08/2005US20050272924 Invention provides a DNA molecule capable of expressing a heterologous polypeptide under cold shock conditions, where the DNA molecule is preferably a self-replicating expression vector
12/08/2005US20050272918 Method of treating allergy using antibody against human interleukin-5 receptor alpha chain
12/08/2005US20050272864 Method and device for improving protein stability and solubility
12/08/2005US20050272684 Breast cancer resistance protein (BCRP) and the DNA which encodes it
12/08/2005US20050272681 Ribosome structure and protein synthesis inhibitors
12/08/2005US20050272678 BMP-6 estrogen responsive element and methods of use thereof
12/08/2005US20050272670 Synthesis and use of glycodendrimer reagents
12/08/2005US20050272664 Methods for inhibiting angiogenesis and or lymphangiogenesis
12/08/2005US20050272662 Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals
12/08/2005US20050272661 providing a neo-tryptophan derivative, andlinking amino acid residues to said neo-tryptophan derivative to form neurotensin polypeptide containing neo-tryptophan
12/08/2005US20050272660 Polypeptide derivatives of parathyroid hormone (PTH)
12/08/2005US20050272659 Helical peptidomimetics with enhanced activity
12/08/2005US20050272658 Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP)
12/08/2005US20050272655 Neonatal Onset Multisystem Inflammatory Disorder, Muckle-Wells Syndrome, Familial Cold Autoinflammatory Syndrome, familial mediterranean fever, tumor necrosis factor receptor-associated periodic fever syndrome, or systemic onset juvenile idiopathic arthritis; interleukin fusion protein antagonist
12/08/2005US20050272654 NF-kappaB activation inhibitors, and their pharmaceutical uses
12/08/2005US20050272653 Bone morphogenic protein fusion for use in treatment and prevention of bone disorders
12/08/2005US20050272652 Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
12/08/2005US20050272651 Methods for treating breast cancer using NRIF3 related molecules
12/08/2005US20050272648 Ghrelin analogs
12/08/2005US20050272643 Removal of serum albumin from human serum or plasma
12/08/2005US20050272633 Derivatives of the nf-kappab inducing enzyme, their preparation and use
12/08/2005US20050272362 Genetic test for PSE-susceptible turkeys
12/08/2005US20050272155 Methods and compositions for enhancing cell adhesion properties
12/08/2005US20050272132 For therapy of a fungal infection
12/08/2005US20050272130 Methods and compositions relating to prion-only transmission of yeast strains
12/08/2005US20050272129 Filamentous fungus belonging to a species Colletotrichum gloeosporioides or Aspergillus niger; improved biomass production in solid and liquid culture; for biocontrol
12/08/2005US20050272127 Antibody against an angiogenesis-inhibiting peptide homologous to human ChM1L chondromodulin-I (ChM-I); hybridomas; diagnostic kits; controlling angiogenesis
12/08/2005US20050272126 Testis-specific differentiation-regulatory factor
12/08/2005US20050272125 Method for making acylated polypeptides
12/08/2005US20050272123 Nucleotide sequence encoding polypeptide; ligand binding to neuromedin; central nervous system and psychological disorders
12/08/2005US20050272122 Novel human G-protein coupled receptor
12/08/2005US20050272120 Compositions and methods for the diagnosis and treatment of tumor
12/08/2005US20050272118 biological conjugated drug binding with a detectable label, or toxin maytansine and calicheamicin; monoclonal antibody as antiinflammatory agents in the therapeutic treatment and diagnostic detection of immune disorders in mammals; biodrugs
12/08/2005US20050272114 wherein mutant hydrolase forms stable bond with rhodococcus dehalogenase substrate; beta-lactamases; fustion proteins; cell labelling; tissue target therapy
12/08/2005US20050272111 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
12/08/2005US20050272099 Nucleic acids encoding androgen receptorl drug screening
12/08/2005US20050272097 Methods and compositions for detecting and treating autoimmune diseases
12/08/2005US20050272094 Purified antigen for Alzheimer's disease and methods of obtaining and using same
12/08/2005US20050272093 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
12/08/2005US20050272091 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection
12/08/2005US20050272090 Nucleic acid binding of multi-zinc finger transcription factors
12/08/2005US20050272089 Critical genes and polypeptides of haemophilus influenzae and methods of use
12/08/2005US20050272077 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
12/08/2005US20050272072 Ligand-dependent protein splicing
12/08/2005US20050272067 Compositions, splice variants and methods relating to cancer specific genes and proteins
12/08/2005US20050272058 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/08/2005US20050272050 Receptor protein for identifying modulators to treat and prevent inflammatory, antherosclerotic and cancer disorders; wound healing agents
12/08/2005US20050272048 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
12/08/2005US20050272045 Anti-Hpr6 agents, to enhance the killing effect of anti-cancer agents in non-sarcoma tumor cells and to teat non-sarcoma tumors
12/08/2005US20050272041 isolated polynucleotide encoding Enzymatic proteins for use in food processing, paper making and recycling
12/08/2005US20050272038 Compositions and methods for diagnosis and therapy of cancers
12/08/2005US20050272031 Viral variants and uses therefor
1 ... 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 ... 2916